Cogent Biosciences (COGT)
(Delayed Data from NSDQ)
$7.56 USD
-0.36 (-4.55%)
Updated May 10, 2024 04:00 PM ET
After-Market: $7.55 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Cogent Biosciences, Inc. [COGT]
Reports for Purchase
Showing records 41 - 60 ( 120 total )
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Bezuclastinib a Bargain Ahead of Multiple Data Catalysts
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- EORTC-NCI-AACR 2022: Covered Companies Roundup
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Relevant Abstracts at Upcoming EORTC-NCI-AACR Meeting
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
KOL Highlights: Discussing Mastocytosis with Dr. Daniel DeAngelo.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
EHA 2022 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
The Sale Won''t Last Long with APEX Data Around the Corner
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Introduces ErbB2 at Investor Day; Tryptase Data Around the Corner
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
COGT Reports 4Q21; APEX Phase 2 on Track for 1H22 Initial Readout
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cogent Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
AACR 2022 Abstract Roundup For Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D